Medeon Biodesign, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 653.900 million compared to TWD 453.763 million a year ago. Operating loss was TWD 96.637 million compared to TWD 257.294 million a year ago. Net loss was TWD 192.735 million compared to TWD 261.985 million a year ago. Basic loss per share was TWD 2.91 compared to TWD 3.96 a year ago.